Randomized trial evaluates TNFSF10's role as a biomarker in testicular germ cell tumors, suggesting its potential for personalized treatment strategies.
Key Points
This research aims to assess TNFSF10 as a prognostic biomarker and therapeutic target in testicular germ cell tumors (TGCTs).
Utilized integrated analysis of Single-Cell RNA-Sequencing and TCGA data.
Evaluated TNFSF10 expression and its correlation with patient survival outcomes.
Investigated the effects of TNFSF10 silencing on TGCT cell behavior.
Aberrant TNFSF10 expression significantly correlates with patient survival outcomes.
Silencing TNFSF10 inhibited TGCT cell proliferation, migration, and invasion.
TNFSF10 expression correlates with components of the tumor microenvironment, impacting treatment response.